Evaluation of the analytical and clinical performance of a high-sensitivity troponin I point-of-care assay in the Mersey Acute Coronary Syndrome Rule Out Study (MACROS-2) - PubMed The whole blood POC TriageTrue hs-TnI assay demonstrates imprecision levels consistent with high sensitivity characteristics and has a clinical performance equivalent to an established, validated and ...

🫀Point-of-care ( #POC) high sensitivity #troponin I ( #hsTnI) testing boosts Acute #Coronary Syndrome detection!

This study proves its efficiency, supporting faster decisions in #emergency care.

Read more:
pubmed.ncbi.nlm.nih.gov/39239902/

Cardiac biomarkers and effects of aficamten in obstructive hypertrophic cardiomyopathy: the SEQUOIA-HCM trial AbstractBackground and Aims. The role of biomarker testing in the management of obstructive hypertrophic cardiomyopathy is not well defined. This pre-speci

🫀This article shows the importance of monitoring #NTproBNP and high sensitivity #troponin I ( #hsTnI) in obstructive hypertrophic cardiomyopathy.

The concentrations of both #biomarkers are crucial to monitor the clinical response to therapy.

European Heart Journal
academic.oup.com/eurheartj/ar...